Revolution Medicines, Inc.
RVMD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001628171
In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 17 sales; 693 institutions reported holding it in 13F filings for Q2 2026, worth $40.1B in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesRVMDW
13F holders, Q1 2022
Institutional positions in Revolution Medicines, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 126
- +10 vs. Q4 2021
- Shares held
- 74.0M
- +623.5K (+0.9%) vs. Q4 2021
- Total value
- $1.89B
- +$39.8M (+2.2%) vs. Q4 2021
- New holders
- 17
- 44 more added
- Sold out
- 7
- 34 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 693 | $40.1B |
| Q1 2026 | 514 | $19.1B |
| Q4 2025 | 387 | $15.9B |
| Q3 2025 | 323 | $8.96B |
| Q2 2025 | 308 | $7.02B |
| Q1 2025 | 284 | $6.83B |
| Q4 2024 | 281 | $8.45B |
| Q3 2024 | 255 | $7.74B |
| Q2 2024 | 223 | $6.54B |
| Q1 2024 | 210 | $5.18B |
| Q4 2023 | 184 | $4.59B |
| Q3 2023 | 168 | $3.11B |
| Q2 2023 | 139 | $2.99B |
| Q1 2023 | 152 | $2.34B |
| Q4 2022 | 135 | $2.10B |
| Q3 2022 | 142 | $1.74B |
| Q2 2022 | 135 | $1.49B |
| Q1 2022 | 126 | $1.89B |
| Q4 2021 | 117 | $1.85B |
| Q3 2021 | 114 | $1.99B |
| Q2 2021 | 130 | $2.23B |
| Q1 2021 | 128 | $3.05B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Revolution Medicines, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ponoi Management, LLC | 685,011 | $17.5M | 22.68% | 00.0% | Unchanged |
| Ponoi II Management, LLC | 685,011 | $17.5M | 38.78% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 869,507 | $22.2M | 0.01% | +175,304+25.3% | Added |
| Deerfield Management Company, L.P. (Series C) | 891,587 | $22.7M | 0.51% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 970,514 | $24.8M | 0.01% | +9,218+1.0% | Added |
| Geode Capital Management, LLC | 1,120,941 | $28.6M | 0.00% | +17,444+1.6% | Added |
| Capital World Investors | 1,228,000 | $31.3M | 0.01% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 1,274,097 | $32.5M | 1.02% | +1,274,097 | New |
| JPMorgan Chase & Co | 1,340,615 | $34.2M | 0.00% | +58,914+4.6% | Added |
| TRV GP IV, LLC | 1,419,900 | $36.2M | 13.27% | 00.0% | Unchanged |
| BVF Inc | 1,810,549 | $46.2M | 1.85% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 1,995,066 | $50.9M | 3.91% | −436,786−18.0% | Reduced |
| Price T Rowe Associates Inc | 2,299,816 | $58.7M | 0.01% | +1,244,045+117.8% | Added |
| Woodline Partners LP | 2,331,395 | $59.5M | 0.99% | −598,643−20.4% | Reduced |
| Casdin Capital, LLC | 2,370,000 | $60.5M | 2.71% | 00.0% | Unchanged |
| State Street Corp | 2,843,477 | $72.5M | 0.00% | +88,844+3.2% | Added |
| FMR LLC | 2,867,020 | $73.1M | 0.01% | −3,234,704−53.0% | Reduced |
| Farallon Capital Management, L.L.C. | 3,250,000 | $82.9M | 0.46% | +500,000+18.2% | Added |
| Bellevue Group AG | 3,310,662 | $84.5M | 0.98% | −159,500−4.6% | Reduced |
| The Column Group LLC | 3,347,245 | $85.4M | 15.83% | 00.0% | Unchanged |
| Boxer Capital, LLC | 3,484,264 | $88.9M | 4.57% | 00.0% | Unchanged |
| Nextech Invest AG | 3,939,529 | $100.5M | 28.69% | +971,315+32.7% | Added |
| Wellington Management Group LLP | 4,083,989 | $104.2M | 0.02% | −426,906−9.5% | Reduced |
| BlackRock Inc. | 5,340,288 | $136.2M | 0.00% | −134,931−2.5% | Reduced |
| TRV GP III, LLC | 5,524,031 | $140.9M | 38.24% | 00.0% | Unchanged |
| Vanguard Group Inc | 6,057,931 | $154.5M | 0.00% | −241,678−3.8% | Reduced |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −55,100−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −22,994−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −19,541−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −13,200−100.0% | Sold out |
| First Quadrant L P | 0 | $0 | 0.00% | −10,700−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −8,944−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −2,485−100.0% | Sold out |
| Bell Investment Advisors, Inc | – | – | – | – | Not filed |